Latest News - Corporate Lawsuits

Tuesday, August 29, 2017

FDA Greenlights Humira Biosim Cyltezo for Multiple Inflammatory Diseases

The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals, Inc.’s Cyltezo™, a biosimilar to Humira®, in a pre-filled syringe for the treatment of multip…

Read the full story

Monday, August 07, 2017

Environmental Groups Sue FDA to Take Formaldehyde Out of Salons

The Environmental Working Group (EWG) and Women’s Voices for the Earth (WVE) are suing the Food and Drug Administration (FDA) because of the group’s failure to act on dangerous hair straig…

Read the full story

Monday, July 17, 2017

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Thursday, November 17, 2016

US Attorney Announces Charges Against Two Executives Tied to Philidor Pharmacy Scheme

The US Attorney’s Office, Southern District of New York has charged two executives in connection with the Philidor Pharmacy scheme that instigated a stock value plunge at Valeant when it was rev…

Read the full story

Monday, January 18, 2016

Class-Action Suit Against EOS Lip Balm Grows

With their colorful egg-shaped containers, palatable price points ($2.99) and assorted fruity and sweet scents, EOS (which stands for Evolution of Smooth) lip balms have been flying off of store shelv…

Read the full story

Monday, August 10, 2015

Court Rules in Favor of Amarin Corp. in "Off-label" Dispute

Amarin Corporation plc (NASDAQ: AMRN) today announced a United States District Court has ruled that Amarin may promote to healthcare professionals certain uses of Am…

Read the full story

Tuesday, December 17, 2013

Cynosure Announces Successful Settlement of Patent Infringement Lawsuits

Cynosure, Inc. will receive $10 million plus future royalty payments under a comprehensive settlement agreement with Tria Beauty, Inc. that ends the patent infringement litigation between Tria and P…

Read the full story

Tuesday, December 04, 2012

Court: Off-label Drug Promotion Is Protected Speech

The 2nd US Circuit Court of Appeals in New York voted 2-1 to overturn a pharmaceutical salesman's conviction for off-label drug marketing, citing violations against his free speech rights under the Fi…

Read the full story

Tuesday, October 09, 2012

Revance Regains Rights to Its Botulinum Toxins

Revance Therapeutics, Inc. announced a settlement and termination agreement for its contractual relationships with Medicis Pharmaceutical Corporation concerning RT001 Botulinum Toxin Type A Topical Ge…

Read the full story

Friday, September 28, 2012

Pharma Penalties Total $10.2B Over Two Years

Pharmaceutical manufacturers have reached a total of 74 settlements, totaling $10.2 billion in financial penalties with federal and state governments between November 2, 2010 and July 18, 2012. That's…

Read the full story

Wednesday, May 02, 2012

Mylan, Impax Win Ruling in Doryx Generics Patent Case

Mylan Inc. (MYL) said it began selling a generic version of the antibiotic Doryx today after a judge ruled it didn’t infringe a patent held by Warner Chilcott (WCRX) Plc.

Read the full story